Chronic inflammation and hemodialysis reduce immune competence of peripheral blood leukocytes in end-stage renal failure patients

被引:22
|
作者
Knerr, K
Füth, R
Hemsen, P
Mohné, W
Heinig, A
Kleophas, W
Scherbaum, WA
Martin, S
机构
[1] Univ Dusseldorf, Leibniz Inst, German Diabet Ctr, German Diabet Clin, D-40225 Dusseldorf, Germany
[2] Kuratorium Heimdialyse, Evangel Krankenhaus, Dusseldorf, Germany
[3] Diabet Schwerpunkttpraxis, Dusseldorf, Germany
关键词
cytokines; immune reactivity; leukocytes; mRNA; renal failure;
D O I
10.1016/j.cyto.2004.12.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immunoincompetence is a profound problem in end-stage renal failure patients undergoing hemodialysis, and chronic inflammation with altered serum levels of inflammation markers has been reported. Gene expression patterns have had little relevance for leukocyte research so far because of limitations in transcript levels and stability. Using a new stimulation system we induced the expression of immune-relevant transcripts in whole blood preparations ex vivo and stabilized transcript levels by preventing RNA degradation and uncontrolled gene induction. Using quantitative real-time PCR we could show that basal TGF-beta mRNA expression is about 2-fold decreased in end-stage renal failure patients, while expression of TNF-alpha becomes 2-fold increased, further doubling during hemodialysis. By short term stimulation with phytohemagglutinin (PHA) for 2 h we tested for the immune competence of peripheral blood leukocytes and demonstrated that hemodialysis decreases TNF-alpha-mediated immune responsiveness more than 3-fold. This study shows by induction and stabilization of immune-relevant transcripts that chronic inflammation and hemodialysis are crucial factors for disturbed immune competence of end-stage renal failure patients. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:132 / 138
页数:7
相关论文
共 50 条
  • [21] Prognosis of bedridden patients with end-stage renal failure after starting hemodialysis
    Sugaya K.
    Hokama A.
    Hayashi E.
    Naka H.
    Oda M.
    Nishijima S.
    Miyazato M.
    Hokama S.
    Ogawa Y.
    Clinical and Experimental Nephrology, 2007, 11 (2) : 147 - 150
  • [22] REMOVAL OF IMIPENEM AND CILASTATIN BY HEMODIALYSIS IN PATIENTS WITH END-STAGE RENAL-FAILURE
    KONISHI, K
    SUZUKI, H
    SARUTA, T
    HAYASHI, M
    DEGUCHI, N
    TAZAKI, H
    HISAKA, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (08) : 1616 - 1620
  • [23] Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients
    Piperi, C
    Kalofoutis, C
    Tzivras, M
    Troupis, T
    Skenderis, A
    Kalofoutis, A
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2004, 265 (1-2) : 57 - 61
  • [24] Inflammation in end-stage renal failure: could it be treated?
    Stenvinkel, P
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 : 33 - 38
  • [25] The effect of hemodialysis on right ventricular functions in patients with end-stage renal failure
    Akkaya, Mehmet
    Erdogan, Ercan
    Sag, Saim
    Ari, Hasan
    Turker, Yasin
    Yilmaz, Mustafa
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2012, 12 (01): : 5 - 10
  • [26] VOLUNTARY WITHDRAWAL FROM HEMODIALYSIS IN END-STAGE RENAL-FAILURE PATIENTS
    KATES, DM
    HAAS, L
    BRUNZELL, J
    SHERRARD, DJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 540 - 540
  • [27] Pharmacokinetics and Pharmacodynamics Of Pegloticase In Patients With End-Stage Renal Failure Receiving Hemodialysis
    Bleyer, Anthony J.
    Wright, David E.
    Glicklich, Alan
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S497 - S498
  • [28] Pharmacokinetics and pharmacodynamics of pegloticase in patients with end-stage renal failure receiving hemodialysis
    Bleyer, Anthony J.
    Wright, David
    Alcorn, Harry
    CLINICAL NEPHROLOGY, 2015, 83 (05) : 286 - 292
  • [29] Quantitative ultrasound of phalanges in patients with end-stage renal failure treated with hemodialysis
    Horvath, C
    Meszaros, S
    Hosszu, E
    Szucs, J
    Szedelyi, N
    Deak, G
    Mucsi, I
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S123 - S123
  • [30] Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients
    C. Piperi
    C. Kalofoutis
    M. Tzivras
    T. Troupis
    A. Skenderis
    A. Kalofoutis
    Molecular and Cellular Biochemistry, 2004, 265 : 57 - 61